wegovy liver disease - Search News

Order byBest matchMost fresh

Novo Nordisk, Food and Drug Administration and Liver

A Common Weight Loss Drug Can Treat Severe Liver Disease, F.D.A. Says

The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on Friday.

· 23h · on MSN

Novo Nordisk's Weight-Loss Drug Wegovy Approved to Treat Liver Disease

Fierce Pharma · 21h

Novo's Wegovy picks up 3rd indication with key FDA approval in the liver disease MASH

· 8h

Novo Nordisk (NVO) Receives FDA Approval for Wegovy

On August 15, Novo Nordisk (NYSE:NVO) announced that the FDA had approved the use of its new drug Wegovy to treat adults with noncirrhotic metabolic dysfunction-associated steatohepatitis.

· 1d

Novo Nordisk's Wegovy Snags Conditional FDA Nod For Fatty Liver Disease

· 23h

Madrigal stock falls after Novo Nordisk’s Wegovy wins FDA approval for MASH

1don MSN

Novo Nordisk Shares Rise After FDA Approves Wegovy for Liver Disease

Novo Nordisk shares climbed after the U.S. Food and Drug Administration approved a new indication for the Danish drugmaker’s blockbuster Wegovy medicine to treat a serious fatty liver disease. Shares in Novo Nordisk rose as much as 5% in early European trading Monday,

Medscape1d

Wegovy Approved for MASH With Fibrosis, No Cirrhosis

Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis but without cirrhosis.